AIDS Research Today is a free monthly online journal that collates and summarizes the latest research about AIDS, including details on testing, treatment, prevention, hiv, life expectancy.

Volume 4 (2007), Issue 4 (April)

1. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
   J Infect Dis, 195(9): 1345-52. [Abstract] [Full-text]
2. Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis.
   J Infect Dis, 195(9): 1303-10. [Abstract] [Full-text]
3. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
   Vaccine, 25(16): 3070-4. [Abstract] [Full-text]
4. The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy.
   Curr Med Res Opin, 23(4): 803-10. [Abstract] [Full-text]
5. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings.
   Clin Infect Dis, 44(9): 1245-8. [Abstract] [Full-text]
6. HIV/AIDS in Pakistan: the battle begins.
   Retrovirology, 4: 22. [Abstract] [Full-text]
7. The stress moderating role of benefit finding on psychological distress and well-being among women living with HIV/AIDS.
   AIDS Behav, 11(3): 421-33. [Abstract] [Full-text]
8. Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
   Vaccine, 25(17): 3277-83. [Abstract] [Full-text]
9. HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans.
   J Infect Dis, 195(10): 1461-71. [Abstract] [Full-text]
10. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection.
    J Infect Dis, 195(10): 1452-60. [Abstract] [Full-text]
11. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    J Infect Dis, 195(10): 1426-36. [Abstract] [Full-text]
12. Antiretroviral therapy for HIV-1-infected children in Haiti.
    J Infect Dis, 195(10): 1411-8. [Abstract] [Full-text]
13. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
    J Infect Dis, 195(10): 1402-10. [Abstract] [Full-text]
14. Children, AIDS and the politics of orphan care in Ethiopia: the extended family revisited.
    Soc Sci Med, 64(10): 2058-69. [Abstract] [Full-text]
15. A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques.
    Virology, 361(1): 68-79. [Abstract] [Full-text]
16. 'Dying twice': a multi-level model of the roots of AIDS stigma in two South African communities.
    J Health Psychol, 12(3): 403-16. [Abstract] [Full-text]
17. Effect of intensive handwashing in the prevention of diarrhoeal illness among patients with AIDS: a randomized controlled study.
    J Med Microbiol, 56: 659-63. [Abstract] [Full-text]
18. Serpin A1 and CD91 as host instruments against HIV-1 infection: are extracellular antiviral peptides acting as intracellular messengers?
    Virus Res, 125(2): 119-34. [Abstract] [Full-text]
19. Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalization.
    Blood, 109(9): 3633-9. [Abstract] [Full-text]
20. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.
    J Acquir Immune Defic Syndr, 45(1): 85-92. [Abstract] [Full-text]
21. Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort.
    J Acquir Immune Defic Syndr, 45(1): 28-33. [Abstract] [Full-text]
22. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
    J Acquir Immune Defic Syndr, 45(1): 66-71. [Abstract] [Full-text]
23. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Am J Epidemiol, 165(10): 1143-53. [Abstract] [Full-text]
24. Prejudice towards chronic diseases: comparison among epilepsy, AIDS and diabetes.
    Seizure, 16(4): 320-3. [Abstract] [Full-text]
25. Bacteremia in adult patients with acquired immunodeficiency syndrome in the northeast of Thailand.
    Int J Infect Dis, 11(3): 226-31. [Abstract] [Full-text]
26. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
    Pediatr Infect Dis J, 26(5): 406-10. [Abstract] [Full-text]

© 2004-2008 AIDS Research Today. All Rights Reserved.